These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39108079)

  • 21. Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics.
    Clancy CJ; Nguyen MH
    Infect Dis Clin North Am; 2022 Dec; 36(4):791-823. PubMed ID: 36328637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
    Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Pascual Á; Rodríguez-Baño J; Martínez-Martínez L; Aguado JM; Torre-Cisneros J
    Transpl Infect Dis; 2022 Aug; 24(4):e13881. PubMed ID: 35691028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trial.
    Stewart AG; Harris PNA; Chatfield MD; Littleford R; Paterson DL
    Trials; 2021 Apr; 22(1):301. PubMed ID: 33888139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
    Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
    J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of ceftazidime/avibactam against Gram-negative strains in Colombia 2014-2018.
    Lemos-Luengas EV; Rentería-Valoyes S; Cárdenas-Isaza P; Ramos-Castaneda JA
    J Glob Antimicrob Resist; 2022 Jun; 29():141-146. PubMed ID: 35257971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018.
    Jean SS; Lee YL; Liu PY; Lu MC; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2022 Jun; 55(3):463-473. PubMed ID: 34503920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
    Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.
    Tamma PD; Sharara SL; Pana ZD; Amoah J; Fisher SL; Tekle T; Doi Y; Simner PJ
    Open Forum Infect Dis; 2019 Aug; 6(8):ofz353. PubMed ID: 31401649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing
    Isler B; Ezure Y; Romero JLG; Harris P; Stewart AG; Paterson DL
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).
    Paul M; Carrara E; Retamar P; Tängdén T; Bitterman R; Bonomo RA; de Waele J; Daikos GL; Akova M; Harbarth S; Pulcini C; Garnacho-Montero J; Seme K; Tumbarello M; Lindemann PC; Gandra S; Yu Y; Bassetti M; Mouton JW; Tacconelli E; Rodríguez-Baño J
    Clin Microbiol Infect; 2022 Apr; 28(4):521-547. PubMed ID: 34923128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics.
    Montiel-Riquelme F; Calatrava-Hernández E; Gutiérrez-Soto M; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33050170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales.
    Jousset AB; Bernabeu S; Emeraud C; Bonnin RA; Lomont A; Zahar JR; Merens A; Isnard C; Soismier N; Farfour E; Fihman V; Yin N; Barraud O; Jacquier H; Ranc AG; Laurent F; Corvec S; d'Epenoux LR; Bille E; Degand N; Plouzeau C; Guillard T; Cattoir V; Mizrahi A; Grillon A; Janvier F; Brun CL; Amara M; Bastide M; Lemonnier A; Dortet L;
    J Glob Antimicrob Resist; 2023 Mar; 32():78-84. PubMed ID: 36708769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftazidime/Avibactam and Other Commonly Used Antibiotics Activity Against Enterobacterales and
    Zalas-Więcek P; Prażyńska M; Pojnar Ł; Pałka A; Żabicka D; Orczykowska-Kotyna M; Polak A; Możejko-Pastewka B; Głowacka EA; Pieniążek I; Pawlik M; Grys M; Bogiel M
    Infect Drug Resist; 2022; 15():1289-1304. PubMed ID: 35370409
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Karlowsky JA; Hackel MA; Wise MG; Six DA; Uehara T; Daigle DM; Cusick SM; Pevear DC; Moeck G; Sahm DF
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0128122. PubMed ID: 36541767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial Resistance Patterns of Gram-negative Bacteria in an Iranian Referral Pediatric Hospital: A Present Danger of New Delhi Metallo-β- lactamase.
    Mahmoudi S; Pourakbari B; Rostamyan M; Raji H; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2023; 23(6):e180423215994. PubMed ID: 37106518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.